Immatics $150 million follow-on offering
We advised Immatics on the offering of shares
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Labcorp $2 billion senior notes offering
The investment-grade notes are due 2030, 2032 and 2034
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
MBX Biosciences $188 million IPO
The shares are listed on the Nasdaq Global Select Market
Terns Pharmaceuticals $173 million stock and pre-funded warrants offering
The shares are listed on the Nasdaq Global Select Market
Ionis Pharmaceuticals $500.3 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Illumina $500 million notes offering
The 4.65% investment-grade notes are due 2026
Jazz Pharmaceuticals $1 billion exchangeable senior notes offering
The exchangeable notes are due 2030
Owens & Minor $1.4 billion Rotech acquisition financing
We are advising the lead arrangers on the financing
Eli Lilly $5 billion notes offering
The investment-grade notes are due 2027, 2029, 2034, 2054 and 2064